The North America Bioreactors Market was worth USD 387.56 million in 2016 and estimated to be growing at a CAGR of 6.35%, to reach USD 527.26 million by 2021. Rising Chronic disease prevalence and increasing biopharmaceutical investments will propel the growth of the market.
Manufacture or production of enzymes, biologically active ingredients like yeast and other materials requires special processing plants that support the biologically active environment. These type of reactors are termed bioreactors.
These devices have enormous applications in fields of biochemical engineering, tissue engineering, drug designing and development.
Primary drivers responsible for the growth of market are increase in incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, rising chronic diseases prevalence, increasing demand for therapeutically active vaccines, product innovation and favourable governments initiatives to develop healthcare infrastructure. Also, factors like Growing personalized medicine market and increasing popularity for them and increasing popularity of single-use bioreactor among the biopharmaceutical companies will also assist the growth of market.
Yet, regulatory issues regarding single-use bioreactors, limited storage and vulnerability to leaching may hinder the growth of market. Furthermore, large scale disposal of plastic derivatives is an environmental concern restraining the growth.
View full report @ www.marketdataforecast.com/market-…tors-market-2960/
The North America market for Bioreactors is segmented based on Material, Scale, Production Size, Control Type, End Users and Suppliers. Based on Material - Glass, Stainless-Steel and Single use.
Based on Scale – 5L-20L, 20L-200L, 200L-1500L and Over 1500L. Based on Production Size – Lab-Scale Production, Pilot-Scale Production, Full-Scale Production.
Based on Control Type – Manual and Automated (MFCs). Based on End Users - R&D Departments, R&D Institutes, CRO’s, Biopharmaceutical Companies, Biopharmaceutical Manufacturers and CMO’s.
Based on Suppliers - OEMs, System Integrators and EPCs. Based on Geographical analysis the market is separated into regions of United States of America and Canada.
USA is leading the market, increasing financial support for development of innovative drugs and increase in no. of biopharmaceutical manufacturers has propelled the growth of the market.
USA is also expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and rapid medical and technological advancements. CMO’s are the major players in terms of end users.
Single-use bioreactors are the most widely used one with 41 % share. Glass bioreactors are majorly used for R&D.
Get free sample report @ www.marketdataforecast.com/market-…60/request-sample
Some of the key players dominating this market include Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and major Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation, Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A.
Enquire now @ www.marketdataforecast.com/cart
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!